Cargando…
Possible association between moderate intellectual disability and weight gain in valproic acid–treated patients with epilepsy
BACKGROUND: Although patients with moderate intellectual disability (ID) are known to have higher rates of being overweight and obese than those without ID, there are no current data regarding the relationship between ID and weight gain in epilepsy patients treated with valproic acid (VPA). PATIENTS...
Autores principales: | Tanamachi, Yukiko, Saruwatari, Junji, Noai, Madoka, Kamihashi, Ryoko, Soraoka, Hiromi, Yoshimori, Yuki, Ogusu, Naoki, Oniki, Kentaro, Yasui-Furukori, Norio, Ishitsu, Takateru, Nakagawa, Kazuko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397927/ https://www.ncbi.nlm.nih.gov/pubmed/25897238 http://dx.doi.org/10.2147/NDT.S80898 |
Ejemplares similares
-
Impact of the Superoxide Dismutase 2 Val16Ala Polymorphism on the Relationship between Valproic Acid Exposure and Elevation of γ-Glutamyltransferase in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis
por: Ogusu, Naoki, et al.
Publicado: (2014) -
Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis
por: Nakashima, Hiroo, et al.
Publicado: (2015) -
Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia
por: Saruwatari, Junji, et al.
Publicado: (2013) -
Update on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy
por: Saruwatari, Junji, et al.
Publicado: (2010) -
Possible impact of the CYP2D6*10 polymorphism on the nonlinear pharmacokinetic parameter estimates of paroxetine in Japanese patients with major depressive disorders
por: Saruwatari, Junji, et al.
Publicado: (2014)